Search Results 7131-7140 of 34574 for oral

1. Ruxolitinib Cream in the Treatment Cutaneous Necrobiosis Lipoidica - Mayo Clinic

   Use of oral, injected or implanted hormonal methods of contraception or other forms or hormonal contraception that have complete efficacy (failure < 1%).

2. A Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Terlipressin Treatment - Mayo Clinic

   Use of short-term (< 2 weeks) oral neomycin for acute encephalopathy is acceptable. Current or recent (within 4 weeks) renal replacement therapy; Superimposed ...

3. A Study of Healthy Donor Volunteers to Provide Blood components Via Leukapheresis for In vitro Dendritic Cell Investigations - Mayo Clinic

   Citrate toxicity in excess of Grade 2 (responds to slowing the rate of the citrate anticoagulant infusion and by administering oral calcium carbonate ...

4. Study Of Lunresertib Alone Or In Combination With RP-3500 Or Debio 0123 In Patients With Advanced Solid Tumors - Mayo Clinic

   Ability to swallow and retain oral medications. Acceptable hematologic and organ function at screening. Negative pregnancy test (serum) for women of ...

5. A Study of XmAb ®18087 in Subjects With NET and GIST - Mayo Clinic

   Highly effective methods of birth control include hormonal birth control (oral, intravaginal, transdermal, implantable, or intrauterine), intrauterine ...

6. Samir H. Patel, M.D. - Doctors and Medical Staff - Mayo Clinic

   Oral and throat cancer; Oropharyngeal cancer; Radiation injury; Salivary gland cancer; Skin cancer · Thyroid cancer · Procedures performed · Intensity-modulated ...

7. Tongue cancer - Doctors and departments - Mayo Clinic

   Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

8. Mouth cancer - Doctors and departments - Mayo Clinic

   Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...

9. Publications - Jose R. Valery, M.D. - Mayo Clinic

   Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants. J Prim Care Community Health. 2022 Jan-Dec ...

10. Efficacy And Safety Of Maribavir In Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory Or Resistant To Treatment - Mayo Clinic

    ... oral/enteral medication. Have known hypersensitivity to the active substance or to an excipient for a study treatment. Have tissue invasive CMV disease with ...